Paragon Associates & Paragon Associates II Joint Venture’s Akoya BioSciences AKYA Stock Holding History

Paragon Associates & Paragon Associates II Joint Venture’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-671,000	Closed	-$872K	–	13
2025 Q2	$872K	Hold	671,000	–	–	1.39%	14
2025 Q1	$933K	Sell	671,000 -130,000	-16%	-$285K	2.19%	9
2024 Q4	$1.83M	Buy	801,000 +11,000	+1%	+$29.1K	4.24%	7
2024 Q3	$2.15M	Buy	790,000 +440,000	+126%	+$1.07M	3.86%	9
2024 Q2	$819K	Buy	+350,000	New	+$1.12M	2%	11

Paragon Associates & Paragon Associates II Joint Venture's AKYA Position: Q3 2025 in Review

Paragon Associates & Paragon Associates II Joint Venture sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 671,000 shares — an estimated $872K sold.

Paragon Associates & Paragon Associates II Joint Venture first reported a position in AKYA in Q2 2024 and held it in 5 quarters. The position peaked at $2.15M in Q3 2024. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

Paragon Associates & Paragon Associates II Joint Venture reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
Paragon Associates & Paragon Associates II Joint Venture sold 671,000 Akoya BioSciences shares in Q3 2025, an estimated $872K.
Paragon Associates & Paragon Associates II Joint Venture first reported a position in Akoya BioSciences in Q2 2024 and held it in 5 quarters.
Paragon Associates & Paragon Associates II Joint Venture's Akoya BioSciences position peaked at $2.15M in Q3 2024.
0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q3 2025, filed 12 Nov 2025.